Cologne was a mixed bag for me anyway.
The numbers circulated about the work in Cologne were exciting, but it never made total sense that Northwest was something new if such a large volume of success had been ongoing for years in Germany. And their treatment regimen was a little different from DCVax-L. So if they had the stats bragged about, you had to wonder if NW should be doing things a little differently. Due to these concerns on my part, I am kind of happy to hear a critique of the work in Cologne.
So, maybe Temador is needed. I have heard over and over again that it is definitely synergistic with DCVax-L when used during the initial stages of treatment. I just think it is transparent that the optimum number of cycles of Temador when DCVax-L is being used will prove to be less than the current SOC. That reduction might be less than one cycle... meaning that there is no need to reduce cycles, but I think that is unlikely. I would guess that there is at least a 33% reduction in the optimum number of Temador cycles in the secondary period. I think that reduction will improve OS while helping offset the cost of DCVax-L. And I'm not a quack... I think you have to be a Doctor to be a quack. I'm a doktor.